SOURCE: ThermaFreeze Products Corp

March 06, 2008 07:00 ET

ThermaFreeze™ Products Corporation Announced Today That BioScan Screening Systems, Inc. Has Adopted ThermaFreeze™ Refrigerant

THEODORE, AL--(Marketwire - March 6, 2008) - ThermaFreeze™ Products Corporation (PINKSHEETS: TFZP) announced today that it has an agreement with BioScan Screening Systems, Inc. for sale of ThermaFreeze™ refrigerant to its commercial and consumer-oriented customers.

BioScan (http://www.bioscaninc.com) sells drug and medical testing devices and consumer products. They have sold ThermaFreeze™ to certain of their perishable shipping and consumer-related customers with considerable success. Peter Welshofer, BioScan President, stated, "Where we have sold ThermaFreeze™ for commercial applications, the customers have all liked ThermaFreeze's™ performance. We look forward to a long-term partnership with ThermaFreeze™ Products."

"Cold chain shipping is a vital component of moving perishable goods safely and in good condition. ThermaFreeze™ Products Corporation is a cold chain shipping solution-based company. Our continuing advances in capacity and customer service, especially with marketing partners like BioScan, all add up to a critical part of our interface with our customers," said Joe Murray, President of ThermaFreeze Products Corp.

About ThermaFreeze

ThermaFreeze™ Products Corporation (http://www.thermafreeze.com) is a solutions-based company for shipment of perishables, including frozen and refrigerated food items and pharmaceutical preparations. ThermaFreeze's™ products are designed to replace wet ice, gel packs and frozen bricks for in-transit temperature control. Through advanced cold chain research, development, experience and perishable field testing, ThermaFreeze™ developed a suite of patented products, processes and systems that provide an economically feasible solution for manufacturers and distributors.

ThermaFreeze™ refrigerant is flat, light-weight and flexible, even when frozen. In addressing industry needs, the goal was to produce a non-toxic, low-weight, flat, highly efficient refrigerant.

ThermaBarrier: a Thermal Packing Product in which all packaging components are non-toxic and safe. ThermaBarrier can be used without restrictions in all markets, for all perishable goods and for medical-pharmaceutical items.

ThermaFreeze provides end-to-end solutions in shipping perishables, built around our proprietary ThermaFreeze refrigerant pads and ThermaBarrier liner products. Use of ThermaFreeze products typically permits 24 hour shipments to be increased to 36 - 48 hours or more, providing significant savings in shipping costs, while also reducing or eliminating spoilage rates.

Legal Notice Regarding Forward-Looking Statements

No statement herein should be considered an offer or a solicitation of an offer for the purchase or sale of any securities. This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although the Company believes that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, it can give no assurance that such expectations and assumptions will prove to have been correct. Forward-looking statements, which involve assumptions and describe our future plans, strategies, and expectations, are generally identifiable by use of the words "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend," or "project" or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to adverse economic conditions, intense competition, lack of meaningful research results, entry of new competitors and products, adverse federal, state and local government regulation, inadequate capital, unexpected costs and operating deficits, increases in general and administrative costs, termination of contracts or agreements, technological obsolescence of the Company's products, technical problems with the Company's research and products, price increases for supplies and components, litigation and administrative proceedings involving the Company, the possible acquisition of new businesses or technologies that result in operating losses or that do not perform as anticipated, unanticipated losses, the possible fluctuation and volatility of the Company's operating results, financial condition and stock price, losses incurred in litigating and settling cases, dilution in the Company's ownership of its business, adverse publicity and news coverage, inability to carry out research, development and commercialization plans, loss or retirement of key executives and research scientists, changes in interest rates, inflationary factors, and other specific risks. The Company undertakes no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect the events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Contact Information